Aeon Global Health (ADAT) Return on Equity ROE from the third quarter 2019 to third quarter 2017 and annually, average high and low, overall ranking from Mar 31 2019 to Dec 31 2016 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aeon Global Health Corp.  (ADAT)

Aeon Global Health's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Aeon Global Health in the third quarter 2019?
Aeon Global Health Corp. recorded a cumulative net loss of $-33 million during 12 months ending in the third quarter 2019, resulting in a negative return on equity (ROE) of -657.88%.

Within the Laboratory Analytical Instruments industry 23 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2018 from to 4389.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2019)
III. Quarter		 (Dec 31 2017)
II. Quarter		 (Sep 30 2017)
I. Quarter		 (Jun 30 2017)
IV. Quarter		 (Dec 31 2016)
II. Quarter
Y / Y Equity Change -96.97 % -88.42 % -82.52 % -80.41 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -33 -33 -30 -33 -7
Return On Equity (TTM) -657.88 % -228.74 % -137.24 % -108.76 % -18.14 %
ADAT's Total Ranking # 4389 # # # #
Equity (TTM) in Millions 1 4 7 8 39
Seq. Equity Change -70 % -42.93 % -13.07 % -79.61 % 14.5 %
Seq. Net Income Change - - - - -

Back to ADAT Management Effectiveness >> ADAT's 5 Years Annual ROE >> Compare ADAT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 24
Sector # 703
Overall # 4389

Return On Equity Statistics
High Average Low
23.64 %
-172.73 %
-657.88 %
(Sep 30 2016)   (Mar 31 2019)





ADAT Annual Return On Equity (Jun 30 2017)
2017		 (Jun 30 2016)
2016


Total Equity in Millions 8 40 0 0 0
Y / Y Equity Change -79.89 % - - - -
Net Income in Millions -32 5 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -399.41 % 13.18 % - - -

Back to ADAT Management Effectiveness >> ADAT's 5 Years Annual ROE >> Compare ADAT ROE to its Competitors




More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ADAT's' Return on Equity at Yahoo Finance
ADAT's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ADAT's Competitors
Subscribers only: Roe for Aeon Global Health's Suppliers
Subscribers only: Return On Equity for ADAT's Customers




Companies with similar Return On Equity at Mar 31 2019, within Healthcare Sector ROE

Date modified: 2026-09-08T15:22:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.